Cargando…
Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission within hospitals. AIMS: We aimed to replicate our earlier s...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914129/ https://www.ncbi.nlm.nih.gov/pubmed/35256037 http://dx.doi.org/10.1192/bjo.2022.31 |
_version_ | 1784667636764770304 |
---|---|
author | Liu, Kathy Y. Kulatilake, Anita Kalafatis, Chris Smith, Gareth King, Jacob D. Serra-Mestres, Jordi Huzzey, Lauren Ng, Nicola Kandangwa, Pooja Elliott, Thomas Sommerlad, Andrew Marston, Louise Livingston, Gill |
author_facet | Liu, Kathy Y. Kulatilake, Anita Kalafatis, Chris Smith, Gareth King, Jacob D. Serra-Mestres, Jordi Huzzey, Lauren Ng, Nicola Kandangwa, Pooja Elliott, Thomas Sommerlad, Andrew Marston, Louise Livingston, Gill |
author_sort | Liu, Kathy Y. |
collection | PubMed |
description | BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission within hospitals. AIMS: We aimed to replicate our earlier study of London mental health in-patients to examine changes in clinical guidance and practice and associated COVID-19 prevalence and outcomes between COVID-19 waves 1 and 2 (1 March to 30 April 2020 and 14 December 2020 to 15 February 2021). METHOD: We collected the 2 month period prevalence of wave 2 of COVID-19 in older (≥65 years) in-patients and those with dementia, as well as patients’ characteristics, management and outcomes, including vaccinations. We compared these results with those of our wave 1 study. RESULTS: Sites reported that routine testing and personal protective equipment were available, and routine patient isolation on admission occurred throughout wave 2. COVID-19 infection occurred in 91/358 (25%; 95% CI 21–30%) v. 131/344, (38%; 95% CI 33–43%) P < 0.001 in wave 1. Hospitals identified more asymptomatic carriers (26/91; 29% v. 16/130; 12%) and fewer deaths (12/91; 13% v. 19/131; 15%; odds ratio = 0.92; 0.37–1.81) compared with wave 1. The patient vaccination uptake rate was 49/58 (85%). CONCLUSIONS: Patients in psychiatric in-patient settings, mostly admitted without known SARS-CoV-2 infection, had a high risk of infection compared with people in the community but lower than that during wave 1. Availability of infection control measures in line with a policy of parity of esteem between mental and physical health appears to have lowered within-hospital COVID-19 infections and deaths. Cautious management of vulnerable patient groups including mental health patients may reduce the future impact of COVID-19. |
format | Online Article Text |
id | pubmed-8914129 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-89141292022-03-11 Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 Liu, Kathy Y. Kulatilake, Anita Kalafatis, Chris Smith, Gareth King, Jacob D. Serra-Mestres, Jordi Huzzey, Lauren Ng, Nicola Kandangwa, Pooja Elliott, Thomas Sommerlad, Andrew Marston, Louise Livingston, Gill BJPsych Open Papers BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) has high morbidity and mortality in older adults and people with dementia. Infection control and prevention measures potentially reduce transmission within hospitals. AIMS: We aimed to replicate our earlier study of London mental health in-patients to examine changes in clinical guidance and practice and associated COVID-19 prevalence and outcomes between COVID-19 waves 1 and 2 (1 March to 30 April 2020 and 14 December 2020 to 15 February 2021). METHOD: We collected the 2 month period prevalence of wave 2 of COVID-19 in older (≥65 years) in-patients and those with dementia, as well as patients’ characteristics, management and outcomes, including vaccinations. We compared these results with those of our wave 1 study. RESULTS: Sites reported that routine testing and personal protective equipment were available, and routine patient isolation on admission occurred throughout wave 2. COVID-19 infection occurred in 91/358 (25%; 95% CI 21–30%) v. 131/344, (38%; 95% CI 33–43%) P < 0.001 in wave 1. Hospitals identified more asymptomatic carriers (26/91; 29% v. 16/130; 12%) and fewer deaths (12/91; 13% v. 19/131; 15%; odds ratio = 0.92; 0.37–1.81) compared with wave 1. The patient vaccination uptake rate was 49/58 (85%). CONCLUSIONS: Patients in psychiatric in-patient settings, mostly admitted without known SARS-CoV-2 infection, had a high risk of infection compared with people in the community but lower than that during wave 1. Availability of infection control measures in line with a policy of parity of esteem between mental and physical health appears to have lowered within-hospital COVID-19 infections and deaths. Cautious management of vulnerable patient groups including mental health patients may reduce the future impact of COVID-19. Cambridge University Press 2022-03-08 /pmc/articles/PMC8914129/ /pubmed/35256037 http://dx.doi.org/10.1192/bjo.2022.31 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Papers Liu, Kathy Y. Kulatilake, Anita Kalafatis, Chris Smith, Gareth King, Jacob D. Serra-Mestres, Jordi Huzzey, Lauren Ng, Nicola Kandangwa, Pooja Elliott, Thomas Sommerlad, Andrew Marston, Louise Livingston, Gill Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 |
title | Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 |
title_full | Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 |
title_fullStr | Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 |
title_full_unstemmed | Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 |
title_short | Infection control and the prevalence, management and outcomes of SARS-CoV-2 infections in mental health wards in London, UK: lessons learned from wave 1 to wave 2 |
title_sort | infection control and the prevalence, management and outcomes of sars-cov-2 infections in mental health wards in london, uk: lessons learned from wave 1 to wave 2 |
topic | Papers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8914129/ https://www.ncbi.nlm.nih.gov/pubmed/35256037 http://dx.doi.org/10.1192/bjo.2022.31 |
work_keys_str_mv | AT liukathyy infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT kulatilakeanita infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT kalafatischris infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT smithgareth infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT kingjacobd infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT serramestresjordi infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT huzzeylauren infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT ngnicola infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT kandangwapooja infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT elliottthomas infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT sommerladandrew infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT marstonlouise infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 AT livingstongill infectioncontrolandtheprevalencemanagementandoutcomesofsarscov2infectionsinmentalhealthwardsinlondonuklessonslearnedfromwave1towave2 |